Tissue Phenomics Blog

5B_Her2-classified.jpg

Posts by Topic

see all

Topics:  personalized medicine, companion diagnostics, Companion Diagnostic Development, biomarker datafication, patient stratification, Biomarker Datafication Services

Powerful, Data Driven Patient Stratification - Improving biomarker performance.

Aug 26, 2015 8:00:00 AM

Personalized v. Standard Care

Why do Pharma companies care about personalized medicine given that this might limit the population for which their drug is approved?

Low response rates to therapy and lack of patient benefit compared to the standard of care can put success of a clinical trial and overall drug development at risk. Therefore pharma companies are invested in diagnostic programs to:

  • select the right patients for their drug
  • minimize the risk of drug failure
  • get drugs to market faster
Read More

Topics:  drug development, tissue phenomics, biomarker expression, biomarker datafication, Definiens, biomarker screening, tissue biomarkers

Biomarker Selection to Accelerate Clinical Development Planning

Jul 7, 2015 9:30:00 AM

Biomarker projects are critical to drug development programs and demonstrating the medical value of therapies. In the planning phase of clinical development, researchers are often looking to achieve the following:

• Clinical researchers want a good understanding of the expected costs of a therapy program and the timelines involved.
• Clinical researchers want to know as early as possible which biomarker and indication combination works best to advance into clinical trials.

When you have multiple potential biomarkers and indications to evaluate for clinical development, you require flexible and fast screening projects to characterize the expression of specific markers in different tumor tissue.

Read More